UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

The New England journal of medicine, 2021-04, Vol.384 (17), p.1589-1600

2021

Volltextzugriff (PDF)

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study

Sexually transmitted diseases, 2019-05, Vol.46 (5), p.279-286

2019

Volltextzugriff (PDF)

Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

The American heart journal, 2021-05, Vol.235, p.1-11

2021

Volltextzugriff (PDF)

Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure

Nuclear medicine communications, 2017-02, Vol.38 (2), p.141-148

2017

Volltextzugriff (PDF)

Abstract PR006: Initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody

Cancer research (Chicago, Ill.), 2022-11, Vol.82 (22_Supplement), p.PR006-PR006

2022

Volltextzugriff (PDF)

470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S230-S230

2019

Volltextzugriff (PDF)

2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S708-S708

2018

Volltextzugriff (PDF)

2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S708-S708

2018

Volltextzugriff (PDF)

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S532-S532

2017

Volltextzugriff (PDF)

Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S533-S533

2017

Volltextzugriff (PDF)

Impact of Delafloxacin (DLX) and Vancomycin/Aztreonam (VAN/AZ) on Resolution of Signs and Symptoms of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S531-S532

2017

Volltextzugriff (PDF)

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S533-S533

2017

Volltextzugriff (PDF)

Evaluation of Digital Versus Manual Measures of Lesion Size in a Phase 3 Trial of Delafloxacin (DLX) in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Likelihood Transformations and Artificial Mixtures

Statistical Modeling for Biological Systems, 2020, p.191-209

2020

Volltextzugriff (PDF)

Deformation behavior of aluminum alloy 6111-T4

Tseng, Carol

2000

Volltextzugriff (PDF)

Smart Contact Lenses: Improving the Vision of Millions

Information display (1975), 2022-01, Vol.38 (1), p.36-37

Tseng, Carol

2022

Volltextzugriff (PDF)

Building a Display Field Leader: SKL's Journey

Information display (1975), 2021-07, Vol.37 (4), p.40-42

Tseng, Carol

2021

Volltextzugriff (PDF)

Student Earns Jsid Award For Work On Lcs For Ar Applications

Information display (1975), 2021-05, Vol.37 (3), p.47-47

Tseng, Carol

2021

Volltextzugriff (PDF)

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors

ChemMedChem, 2021-03, Vol.16 (6), p.942-948

2021

Volltextzugriff (PDF)

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2021-05, Vol.325 (19), p.1965

2021

Volltextzugriff (PDF)

Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial

Journal of general internal medicine : JGIM, 2019-11, Vol.34 (11), p.2652-2659

2019

Volltextzugriff (PDF)

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2021-03, Vol.325 (10), p.962

2021

Volltextzugriff (PDF)

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2022-04, Vol.327 (16), p.1577

2022

Volltextzugriff (PDF)

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2021-08, Vol.326 (8), p.736

2021

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(192)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study

Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure

Abstract PR006: Initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody

470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy

2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ)

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens

Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies

Impact of Delafloxacin (DLX) and Vancomycin/Aztreonam (VAN/AZ) on Resolution of Signs and Symptoms of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens

Evaluation of Digital Versus Manual Measures of Lesion Size in a Phase 3 Trial of Delafloxacin (DLX) in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Likelihood Transformations and Artificial Mixtures

Deformation behavior of aluminum alloy 6111-T4

Smart Contact Lenses: Improving the Vision of Millions

Building a Display Field Leader: SKL's Journey

Student Earns Jsid Award For Work On Lcs For Ar Applications

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement

Aktive Filter

Suchergebnisse filtern